<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03866772</url>
  </required_header>
  <id_info>
    <org_study_id>0166-18-BNZ</org_study_id>
    <nct_id>NCT03866772</nct_id>
  </id_info>
  <brief_title>Labor Induction With Double Balloon Device, Oral Misoprostol and Concomitant Use of Both</brief_title>
  <acronym>IDOM</acronym>
  <official_title>Labor Induction With Double Balloon Device, Oral Misoprostol and Concomitant Use of Both. Multicenter Randomized Controlled Trial- IDOM Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bnai Zion Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bnai Zion Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the rate of cesarean delivery between 3 methods of labor
      induction: double balloon device, oral misoprostol and combination of the two.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Induction of labor is a common obstetrical procedure. It accounts for 20% of laboring women
      worldwide.

      In the past, studies showed that cesarean delivery rates (CDR) are higher in women who are
      induced. These studies were comparing induction to spontaneous labor, which is not the
      management in practice, and when the comparison was made between induction and expectant
      management, the conclusion was that the induction does not increase CDR and can even reduce
      its' rate.

      Failure of induction depends on the definition, and even among randomized controlled trials,
      this definition may vary greatly.

      The decision whether to use a mechanical or pharmacological agent depends on Bishop score,
      parity, contraindications to one of the methods and patient-doctor preference.

      Recently, more data are available regarding induction with oral misoprostol (OM) and this
      method is becoming more popular because OM is effective, safe, convenient, cheap and easy to
      administer.

      If mechanical induction is preferable, either single or double balloon device (DBD) can be
      used. These methods have been previously studied and neither found to be superior.

      A recent study showed that, insertion of the DBD for 6 hours in nulliparous women, results in
      shorter time to delivery (26 hours vs. 31.4 hours, p=0.015), similar Bishop score after
      removal ( 5.74 vs. 5.26, p=0.2) without increasing the rate of cesarean deliveries (19% vs
      32%, p=0.135) when compared to insertion of the DBD for 12 hours as instructed by the
      manufacturer. Several studies have shown that a combination of pharmacological and single
      balloon device results in higher rates to achieve vaginal delivery when compared to each
      method separately

      The investigators hypothesize that with the combination of DBD for 6 hours and OM we will be
      able to reduce the rate of cesarean deliveries when compared to each method separately.

      To date, there are no studies that compared double balloon device with oral misoprostol used
      concomitantly.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the rate of cesarean delivery</measure>
    <time_frame>from induction until delivery</time_frame>
    <description>percentage of cesarean delivery from all deliveries</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bishop score difference between groups</measure>
    <time_frame>after 6 hours and after 24 hours</time_frame>
    <description>cervical change evaluation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>time to delivery</measure>
    <time_frame>from induction to delivery and from ruptured membranes to delivery</time_frame>
    <description>Mean time to delivery</description>
  </other_outcome>
  <other_outcome>
    <measure>Use of other ripening methods after &quot;failure&quot; of the allocated method</measure>
    <time_frame>24 hours after initiation of the treatment</time_frame>
    <description>if the allocated measure was defined as &quot;failed&quot; after 24 hours, other methods will be used to ripen the cervix.</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of achieving active phase of labor (≥ 5 cm cervical dilatation)</measure>
    <time_frame>within 24 hours of initiation</time_frame>
    <description>how many women had more than 5 cm cervical dilatation</description>
  </other_outcome>
  <other_outcome>
    <measure>Cesarean delivery indication (non progressive labor or non reassuring fetal heart rate NRFHR)</measure>
    <time_frame>from initiation until cesarean delivery</time_frame>
    <description>what was the indication for surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Maternal morbidity</measure>
    <time_frame>from initiation until delivery</time_frame>
    <description>advanced tears (3rd and 4th degree) post partum hemorrhage uterine rupture, amnionitis</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient satisfaction - by questioner</measure>
    <time_frame>within 5 days from delivery</time_frame>
    <description>question addressing pain (bearable or unbearable, was the treatment comfortable for the women and would she do it again if necessary</description>
  </other_outcome>
  <other_outcome>
    <measure>tachysystole</measure>
    <time_frame>from initiation until delivery</time_frame>
    <description>more than 5 contractions in 10 min with or without fetal heart rate changes</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal morbidity:</measure>
    <time_frame>within 5 days from delivery</time_frame>
    <description>neonatal care unit admission, meconium with\without fetal heart rate changes, Apgar 5' &lt;7 ,</description>
  </other_outcome>
  <other_outcome>
    <measure>use of oxytocin</measure>
    <time_frame>within 24 hours</time_frame>
    <description>if it was in use at all (yes\no) and if yes- so for how long (time from initiation until delivery)</description>
  </other_outcome>
  <other_outcome>
    <measure>use of emergent tocolysis</measure>
    <time_frame>from induction until delivery</time_frame>
    <description>IV atosiban for tachysystole</description>
  </other_outcome>
  <other_outcome>
    <measure>how many doses of misoprostol</measure>
    <time_frame>from induction until delivery</time_frame>
    <description>counting the number of administered doses</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>MISOPROSTOL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral misoprostol, 50 microgram, every 4 hours
Repeat treatment every 4 hours until active labour begins: regular painful contractions (≥ 3 in 10 min), cervical dilatation ≥ 3 cm
maximal number of doses: 6
Oxytocin infusion can be initiated 4 hours after the last dose of Misoprostol.
Failure of induction will be considered if no cervical change nor uterine contractions have begun during 24 hours of treatment.
Electronic fetal monitoring should be performed for 30 min after administration of misoprostol and 60 min after any tachysystole.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DOUBLE BALLOON</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Insertion of the DBD as instructed by the manufacturer, removal after 6 hours.
Artificial rupture of membranes (AROM) if suitable + IV oxytocin administration
If AROM cannot be performed- oxytocin infusion will be initiated at first.
If Bishop &lt;3 after DBD removal, clinical evaluation and lag time before considering other methods for ripening is suitable and is up to the physician on call.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MISOPROSTOL+DOUBLE BALLOON</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol Oral Tablet</intervention_name>
    <description>50 mcg oral consumption</description>
    <arm_group_label>MISOPROSTOL</arm_group_label>
    <arm_group_label>MISOPROSTOL+DOUBLE BALLOON</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>double balloon device for cervical ripening</intervention_name>
    <description>insertion for 6 hours and followed by the above mentioned protocol</description>
    <arm_group_label>DOUBLE BALLOON</arm_group_label>
    <arm_group_label>MISOPROSTOL+DOUBLE BALLOON</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unfavourable cervix (Bishop score ≤ 4),

          -  indication for induction of labor (medical or obstetrical),

          -  37 completed gestational weeks,

          -  vertex presentation,

          -  singleton pregnancy

          -  intact membranes.

        Exclusion Criteria:

          -  previous cesarean delivery

          -  previous uterine surgery (eg: myomectomy)

          -  noncephalic presentation

          -  multiple pregnancy

          -  pre-eclampsia with severe features

          -  oligohydramnios (Maximal vertical pocket ≤2)

          -  estimated fetal weight &lt;10% percentile

          -  any contraindication to Vaginal delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant population</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Inna Bleicher, Dr</last_name>
    <phone>+972506268345</phone>
    <email>innakreinin@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bnai Zion Mc</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>INNA BLEICHER, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>ACOG Committee on Practice Bulletins -- Obstetrics. ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-97. doi: 10.1097/AOG.0b013e3181b48ef5. Review.</citation>
    <PMID>19623003</PMID>
  </reference>
  <reference>
    <citation>Guise, J.-M. &amp; Rouse, D. J. Safe prevention of the primary cesarean delivery. (2014). doi:10.1016/j.ajog.2014.01.026</citation>
  </reference>
  <reference>
    <citation>Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566.</citation>
    <PMID>30089070</PMID>
  </reference>
  <reference>
    <citation>Schoen C, Navathe R. Failed induction of labor. Semin Perinatol. 2015 Oct;39(6):483-7. doi: 10.1053/j.semperi.2015.07.013. Epub 2015 Sep 2. Review.</citation>
    <PMID>26341068</PMID>
  </reference>
  <reference>
    <citation>Grobman WA, Bailit J, Lai Y, Reddy UM, Wapner RJ, Varner MW, Thorp JM Jr, Leveno KJ, Caritis SN, Prasad M, Tita ATN, Saade G, Sorokin Y, Rouse DJ, Blackwell SC, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Defining failed induction of labor. Am J Obstet Gynecol. 2018 Jan;218(1):122.e1-122.e8. doi: 10.1016/j.ajog.2017.11.556. Epub 2017 Nov 11.</citation>
    <PMID>29138035</PMID>
  </reference>
  <reference>
    <citation>Penfield CA, Wing DA. Labor Induction Techniques: Which Is the Best? Obstet Gynecol Clin North Am. 2017 Dec;44(4):567-582. doi: 10.1016/j.ogc.2017.08.011. Review.</citation>
    <PMID>29078939</PMID>
  </reference>
  <reference>
    <citation>Weeks AD, Navaratnam K, Alfirevic Z. Simplifying oral misoprostol protocols for the induction of labour. BJOG. 2017 Oct;124(11):1642-1645. doi: 10.1111/1471-0528.14657. Epub 2017 May 15.</citation>
    <PMID>28342186</PMID>
  </reference>
  <reference>
    <citation>Salim R, Schwartz N, Zafran N, Zuarez-Easton S, Garmi G, Romano S. Comparison of single- and double-balloon catheters for labor induction: a systematic review and meta-analysis of randomized controlled trials. J Perinatol. 2018 Mar;38(3):217-225. doi: 10.1038/s41372-017-0005-7. Epub 2017 Dec 4.</citation>
    <PMID>29203813</PMID>
  </reference>
  <reference>
    <citation>Husain S, Husain S, Izhar R. Oral misoprostol alone versus oral misoprostol and Foley's catheter for induction of labor: A randomized controlled trial. J Obstet Gynaecol Res. 2017 Aug;43(8):1270-1277. doi: 10.1111/jog.13354. Epub 2017 May 31.</citation>
    <PMID>28561987</PMID>
  </reference>
  <reference>
    <citation>Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2016 Dec;128(6):1357-1364.</citation>
    <PMID>27824758</PMID>
  </reference>
  <reference>
    <citation>Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BW, Irion O, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001233. doi: 10.1002/14651858.CD001233.pub2. Review.</citation>
    <PMID>22419277</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>March 3, 2019</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2019</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bnai Zion Medical Center</investigator_affiliation>
    <investigator_full_name>Inna.bleicher</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <keyword>induction of labor</keyword>
  <keyword>unfavorable cervix</keyword>
  <keyword>misoprostol</keyword>
  <keyword>cytotec</keyword>
  <keyword>double balloon device</keyword>
  <keyword>cervical ripening</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

